ArticleCells2024

Advancing Lung Cancer Treatment with Combined c-Met Promoter-Driven Oncolytic Adenovirus and Rapamycin.

Shih-Yao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.